I. Ohizumi

发表

Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: a novel drug carrier for cancer targeting therapy

Y. Tsutsumi, T. Mayumi, H. Saito, 1999, British Journal of Cancer.

A new disulfide‐linked dimer of a single‐chain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor‐1α pathway

M. Kizaki, Y. Ikeda, Y. Kikuchi, 2011, Cancer science.

Identification of tumor vascular antigens by monoclonal antibodies prepared from rat‐tumor‐derived endothelial cells

Y. Tsutsumi, S. Nakagawa, T. Mayumi, 1998, International journal of cancer.

Human Liver Cancer Glypican 3 Antibody as a Potential Antitumor Agent for − Anti

H. Aburatani, T. Kodama, M. Tsuchiya, 2008 .

Thiochroman derivative CH4986399, a new nonsteroidal estrogen receptor down-regulator, is effective in breast cancer models.

R. Nakamura, K. Taniguchi, S. Kaiho, 2010, Anticancer research.

Newly discovered orally active pure antiestrogens.

Y. Nabuchi, Hyun‐Suk Lim, K. Taniguchi, 2006, Bioorganic & medicinal chemistry letters.

Discovery of thiochroman derivatives bearing a carboxy-containing side chain as orally active pure antiestrogens.

Y. Nabuchi, Hyun‐Suk Lim, K. Taniguchi, 2006, Bioorganic & medicinal chemistry letters.

Discovery of thiochroman and chroman derivatives as pure antiestrogens and their structure-activity relationship.

Hyun‐Suk Lim, K. Taniguchi, Myung-Hwa Kim, 2006, Bioorganic & medicinal chemistry.

Therapy of rat tracheal carcinoma IC-12 in SCID mice: vascular targeting with [213Bi]-MAb TES-23.

S. Kennel, S. Mirzadeh, L. Foote, 2002, European journal of cancer.

Effective Cancer Targeting Using an Anti‐tumor Tissue Vascular Endotheliumspecific Monoclonal Antibody (TES‐23)

Y. Tsutsumi, S. Nakagawa, T. Mayumi, 2000, Japanese journal of cancer research : Gann.

Molecular cloning and characterization of antigens expressed on rat tumor vascular endothelial cells

Y. Tsutsumi, S. Nakagawa, T. Mayumi, 2000, International journal of cancer.

Recognition of human activated CD44 by tumor vasculature-targeted antibody.

Y. Tsutsumi, T. Mayumi, S. Nakagawa, 2000, Biochemical and biophysical research communications.

Tumor vascular targeting using a tumor-tissue endothelium-specific monoclonal antibody as an effective strategy for cancer chemotherapy.

Y. Tsutsumi, T. Mayumi, S. Nakagawa, 1999, Biochemical and biophysical research communications.

Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells.

H. Aburatani, T. Kodama, M. Tsuchiya, 2009, Biochemical and biophysical research communications.

Viral envelope protein gp64 transgenic mouse facilitates the generation of monoclonal antibodies against exogenous membrane proteins displayed on baculovirus.

T. Kodama, K. Jishage, O. Ueda, 2007, Journal of immunological methods.

Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer.

H. Aburatani, T. Kodama, M. Tsuchiya, 2008, Cancer research.

Recovery of functional peptide transporter PepT1 in budded baculovirus fraction.

T. Kodama, M. Tsuchiya, J. Nezu, 2006, Protein expression and purification.

A novel styryl diphenylamine derivative reverts the transformed phenotype of human fibrosarcoma HT1080 cells.

M. Tanemura, I. Ohizumi, S. Kaihoh, 1995, British Journal of Cancer.

Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma

H. Aburatani, M. Makuuchi, T. Kodama, 2004, Cancer Research.

Identification of Soluble NH 2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma

H. Aburatani, M. Makuuchi, T. Kodama, 2004 .

Association of CD44 with OTS-8 in tumor vascular endothelial cells.

Y. Tsutsumi, T. Mayumi, S. Nakagawa, 2000, Biochimica et biophysica acta.

Antibody-based therapy targeting tumor vascular endothelial cells suppresses solid tumor growth in rats.

Y. Tsutsumi, T. Mayumi, S. Nakagawa, 1997, Biochemical and biophysical research communications.